EMA — authorised 7 January 2021
- Marketing authorisation holder: ROCHE REGISTRATION GmbH
- Status: approved
🇪🇺 Xofluza in European Union
EMA authorised Xofluza on 7 January 2021
Marketing authorisation
Xofluza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in European Union
Frequently asked questions
Is Xofluza approved in European Union?
Yes. EMA authorised it on 7 January 2021.
Who is the marketing authorisation holder for Xofluza in European Union?
ROCHE REGISTRATION GmbH holds the EU marketing authorisation.